Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease: Lights and Shadows
Abstract
Rheumatoid arthritis (RA) is a chronic and systemic inflammatory disease affecting 0.5-1% of the population worldwide. Interstitial lung disease (ILD) is a serious pulmonary complication of RA and it is responsible for 10-20% of mortality, with a mean survival of 5-8 years. However, nowadays there are no therapeutic recommendations for the treatment of RA-ILD. Therapeutic options for RA-ILD are complicated by the possible pulmonary toxicity of...
Paper Details
Title
Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease: Lights and Shadows
Published Date
Apr 10, 2020
Journal
Volume
9
Issue
4
Pages
1082 - 1082
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History